Search research articles
Contact Us
Filters
Showing results (51-60 of 64) with videos related to
Page
of 7
Sort By:
Therapeutic Advances in Cardiovascular Disease
|
February 28, 2016
Adverse cardiovascular events in acute coronary syndrome with indications for anticoagulation
Stacey Knight, Raymond O McCubrey, Zhong Yuan, et al.
The New England Journal of Medicine
|
May 2, 2003
Nitroprusside in critically ill patients with left ventricular dysfunction and aortic stenosis
Umesh N Khot, Gian M Novaro, Zoran B Popović, et al.
Clinical Cardiology
|
October 17, 2012
Outcomes associated with warfarin use in older patients with heart failure and atrial fibrillation and a cardiovascular implantable electronic device: findings from the ADHERE registry linked to Medicare claims
Paul L Hess, Melissa A Greiner, Gregg C Fonarow, et al.
American Heart Journal
|
November 2, 2013
Warfarin use among older atrial fibrillation patients with non-ST-segment elevation myocardial infarction managed with coronary stenting and dual antiplatelet therapy
Emil L Fosbol, Tracy Y Wang, Shuang Li, et al.
American Heart Journal
|
June 20, 2012
B-type natriuretic peptide level and postdischarge thrombotic events in older patients hospitalized with heart failure: insights from the Acute Decompensated Heart Failure National Registry
Robb D Kociol, Melissa A Greiner, Bradley G Hammill, et al.
Journal of the American Heart Association
|
July 23, 2013
Provider specialty and atrial fibrillation treatment strategies in United States community practice: findings from the ORBIT-AF registry
Emil L Fosbol, DaJuanicia N Holmes, Jonathan P Piccini, et al.
The American Journal of Cardiology
|
October 23, 2008
Illicit stimulant use in a United States heart failure population presenting to the emergency department (from the Acute Decompensated Heart Failure National Registry Emergency Module)
Deborah B Diercks, Gregg C Fonarow, J Douglas Kirk, et al.
European Journal of Heart Failure
|
April 29, 2015
Rationale and design of a randomized, double-blind, event-driven, multicentre study comparing the efficacy and safety of oral rivaroxaban with placebo for reducing the risk of death, myocardial infarction or stroke in subjects with heart failure and significant coronary artery disease following an exacerbation of heart failure: the COMMANDER HF trial
Faiez Zannad, Barry Greenberg, John G F Cleland, et al.
The American Journal of Cardiology
|
July 16, 2013
Comparative effectiveness of pharmacotherapies for prevention of atrial fibrillation following coronary artery bypass surgery
Jonathan P Piccini, Yue Zhao, Benjamin A Steinberg, et al.
American Heart Journal
|
April 24, 2012
Safety and effectiveness of antithrombotic strategies in older adult patients with atrial fibrillation and non-ST elevation myocardial infarction
Emil L Fosbol, Tracy Y Wang, Shuang Li, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 64) with videos related to
Sort By:
Page
of 7
Therapeutic Advances in Cardiovascular Disease
|
February 28, 2016
Adverse cardiovascular events in acute coronary syndrome with indications for anticoagulation
Stacey Knight, Raymond O McCubrey, Zhong Yuan, et al.
The New England Journal of Medicine
|
May 2, 2003
Nitroprusside in critically ill patients with left ventricular dysfunction and aortic stenosis
Umesh N Khot, Gian M Novaro, Zoran B Popović, et al.
Clinical Cardiology
|
October 17, 2012
Outcomes associated with warfarin use in older patients with heart failure and atrial fibrillation and a cardiovascular implantable electronic device: findings from the ADHERE registry linked to Medicare claims
Paul L Hess, Melissa A Greiner, Gregg C Fonarow, et al.
American Heart Journal
|
November 2, 2013
Warfarin use among older atrial fibrillation patients with non-ST-segment elevation myocardial infarction managed with coronary stenting and dual antiplatelet therapy
Emil L Fosbol, Tracy Y Wang, Shuang Li, et al.
American Heart Journal
|
June 20, 2012
B-type natriuretic peptide level and postdischarge thrombotic events in older patients hospitalized with heart failure: insights from the Acute Decompensated Heart Failure National Registry
Robb D Kociol, Melissa A Greiner, Bradley G Hammill, et al.
Journal of the American Heart Association
|
July 23, 2013
Provider specialty and atrial fibrillation treatment strategies in United States community practice: findings from the ORBIT-AF registry
Emil L Fosbol, DaJuanicia N Holmes, Jonathan P Piccini, et al.
The American Journal of Cardiology
|
October 23, 2008
Illicit stimulant use in a United States heart failure population presenting to the emergency department (from the Acute Decompensated Heart Failure National Registry Emergency Module)
Deborah B Diercks, Gregg C Fonarow, J Douglas Kirk, et al.
European Journal of Heart Failure
|
April 29, 2015
Rationale and design of a randomized, double-blind, event-driven, multicentre study comparing the efficacy and safety of oral rivaroxaban with placebo for reducing the risk of death, myocardial infarction or stroke in subjects with heart failure and significant coronary artery disease following an exacerbation of heart failure: the COMMANDER HF trial
Faiez Zannad, Barry Greenberg, John G F Cleland, et al.
The American Journal of Cardiology
|
July 16, 2013
Comparative effectiveness of pharmacotherapies for prevention of atrial fibrillation following coronary artery bypass surgery
Jonathan P Piccini, Yue Zhao, Benjamin A Steinberg, et al.
American Heart Journal
|
April 24, 2012
Safety and effectiveness of antithrombotic strategies in older adult patients with atrial fibrillation and non-ST elevation myocardial infarction
Emil L Fosbol, Tracy Y Wang, Shuang Li, et al.
Page
of 7